EMID: Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor
Study Details
Study Description
Brief Summary
The endomicroscopy is an adaptation of traditional optical microscopy in the digestive endoscopy. Furthermore, with the integration of a miniaturized laser confocal microscope to a videoendoscope, it's possible to study the digestive mucous by "optical biopsy". This monocentric, non randomized and prospective study uses the Intra-ductal confocal endomicroscopy for the characterization of pancreas and bile duct tumor.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Primary objective:
Obtain a tissular characterization of a biliary or pancreatic stenosis with a confocal microscope which is in direct contact of the stenosis during the Endoscopic Retrograde Cholangio-Pancreatography (ERCP).
Secondary objectives:
-
Compare the result of this "optical biopsy" to a conventional biopsy.
-
Tolerance
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: endomicroscopy Utilisation of an intra-ductal confocal endomicroscopy during the endoscopic Retrograde Cholangio-Pancreatography |
Procedure: Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
Utilisation of the Intra-ductal confocal endomicroscopy to obtain any exploitable image for the anatomopathology.
|
Outcome Measures
Primary Outcome Measures
- The principal outcome is the percentage of successful in vivo examination according to the localisation of the stenosis. A successful examination is defined by the obtention of exploitable image for the anatomopathology. [2 days]
Secondary Outcome Measures
- Study of the concordance between optical and histological biopsy [2 days]
- Frequency and grade of adverse effects induced by the confocal endomicroscopy [2 days]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients aged from 18 to older
-
Patient with an inflammatory or tumoral stenosis of bile duct or a solid or cystic tumor in the pancreas with a dilatation of the principal pancreatic canal.
-
Signed consent
Non inclusion Criteria:
-
Patient who have no indication for an ERCP
-
Allergy to fluorescein
-
Allergic rhinitis, asthma, eczema
-
Pregnancy, breast feeding
-
Patients with dialysis
-
Patient with severe heart failure
-
Patient with cirrhosis
-
Hemostasis failure which can induce difficulties or contraindication for the biopsy during the conventional endoscopy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Institut PAOLI-CALMETTES | Marseille | France | ||
2 | Centre Hospitalier Princesse Grasse | Monaco | Monaco |
Sponsors and Collaborators
- Institut Paoli-Calmettes
Investigators
- Principal Investigator: Marc GIOVANNINI, MD, Institut Paoli-Calmettes
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- EMID/IPC 2008-001